DR Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Lu Yiwen

İcra Kurulu Başkanı

CN¥1.9m

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	1.3yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	4.4yrs

Son yönetim güncellemeleri

Recent updates

Is DR (SZSE:301177) Weighed On By Its Debt Load?

Oct 29

DR's (SZSE:301177) Shareholders Have More To Worry About Than Only Soft Earnings

Sep 05

CEO Tazminat Analizi

Lu Yiwen'un ücretlendirmesi DR'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	CN¥15m
Jun 30 2024	n/a	n/a	CN¥48m
Mar 31 2024	n/a	n/a	-CN¥3m
Dec 31 2023	CN¥2m	n/a	CN¥69m
Sep 30 2023	n/a	n/a	CN¥31m
Jun 30 2023	n/a	n/a	CN¥204m
Mar 31 2023	n/a	n/a	CN¥454m
Dec 31 2022	CN¥2m	n/a	CN¥729m
Sep 30 2022	n/a	n/a	CN¥1b
Jun 30 2022	n/a	n/a	CN¥1b
Mar 31 2022	n/a	n/a	CN¥1b
Dec 31 2021	CN¥2m	n/a	CN¥1b
Sep 30 2021	n/a	n/a	CN¥1b
Jun 30 2021	n/a	n/a	CN¥1b
Mar 31 2021	n/a	n/a	CN¥810m
Dec 31 2020	CN¥2m	CN¥2m	CN¥563m

Tazminat ve Piyasa: Lu 'nin toplam tazminatı ($USD 263.34K ), CN pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 165.22K ).

Tazminat ve Kazançlar: Lu 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Lu Yiwen (37 yo)

1.3yrs

Görev süresi

CN¥1,908,000

Tazminat

Ms. Lu Yiwen is General Manager of DR Corporation Limited August 25, 2023 and its Non-Independent Director since July 11, 2019. She was Deputy General Manager of DR Corporation Limited from July 2019 to Au...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Lu Yiwen	GM & Director	5.3yrs	CN¥1.91m	Veri yok
Shuirong Huang	Deputy GM	5.3yrs	CN¥1.34m	Veri yok
Qisheng Chen	Head of Loose Rock Procurement & Director	3.7yrs	CN¥701.20k	Veri yok
Yingfeng Huang	Chairman of the Board of Supervisors	2.3yrs	Veri yok	Veri yok
Guotao Zhang	Chairman	5.3yrs	CN¥4.18m	Veri yok
Xiaoming Hu	Non-Independent Director	5.3yrs	CN¥671.20k	Veri yok
Yang Li	Independent Director	4.8yrs	CN¥100.00k	Veri yok
Jun Liang	Independent Director	4.8yrs	CN¥100.00k	Veri yok
Min Zhong	Independent Director	4yrs	CN¥100.00k	Veri yok
Ai Shen	Non-Employee Supervisor	2.3yrs	Veri yok	Veri yok
Wanhong Wu	Employee Representative Supervisor	1.6yrs	Veri yok	Veri yok
Ranran Zhao	Director	1.5yrs	CN¥560.50k	Veri yok

4.4yrs

Ortalama Görev Süresi

38.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 301177 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.4 yıldır).

DR Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

DR Corporation Limited, Annual General Meeting, May 28, 2024

DR Corporation Limited, Annual General Meeting, May 28, 2024

High number of new directors

High number of new directors

DR Corporation Limited Announces Management Changes

High number of new and inexperienced directors

Recent updates

Consensus EPS estimates fall by 78%

Third quarter 2024 earnings released: CN¥0.032 loss per share (vs CN¥0.059 profit in 3Q 2023)

Is DR (SZSE:301177) Weighed On By Its Debt Load?

DR Corporation Limited to Report Q3, 2024 Results on Oct 30, 2024

DR's (SZSE:301177) Shareholders Have More To Worry About Than Only Soft Earnings

Second quarter 2024 earnings released: EPS: CN¥0.008 (vs CN¥0.11 loss in 2Q 2023)

Subdued Growth No Barrier To DR Corporation Limited's (SZSE:301177) Price

DR Corporation Limited to Report First Half, 2024 Results on Aug 30, 2024

DR (SZSE:301177) Has Announced That Its Dividend Will Be Reduced To CN¥0.50

Dividend reduced to CN¥0.50

DR Corporation Limited, Annual General Meeting, May 28, 2024

DR Corporation Limited, Annual General Meeting, May 28, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

DR Corporation Limited to Report Q1, 2024 Results on Apr 27, 2024

Is DR (SZSE:301177) A Risky Investment?

DR Corporation Limited to Report Fiscal Year 2023 Results on Apr 26, 2024

Consensus EPS estimates fall by 24%

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.48 in 3Q 2022)

DR Corporation Limited Announces 2022 Cash Dividend (Tax Included), Payable on 20 June 2023

Dr Corporation Limited Approves Cash Dividend for the Year 2022

Now 21% undervalued after recent price drop

High number of new directors

Price target decreased by 19% to CN¥57.62

First quarter 2023 earnings released: EPS: CN¥0.25 (vs CN¥0.94 in 1Q 2022)

Now 20% undervalued

Investor sentiment improved over the past week

Investor sentiment improved over the past week

High number of new directors

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.48 (vs CN¥0.73 in 3Q 2021)

Consensus revenue estimates fall by 10%

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: CN¥0.51 (vs CN¥1.13 in 2Q 2021)

DR Corporation Limited Announces Management Changes

Now 21% undervalued after recent price drop

DR Corporation Limited Announces Final Dividend on A Shares for 2021, Payable on 30 June 2022

Now 21% undervalued after recent price drop

Investor sentiment improved over the past week

DR Corporation Limited Approves Cash Dividend for the Year 2021

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

High number of new and inexperienced directors

DR Corporation Limited, Annual General Meeting, May 20, 2022

DR Corporation Limited Proposes Final Cash Dividend for the Year 2021

Now 22% undervalued after recent price drop

Now 20% undervalued

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş